David Lemus

  • Mr. Lemus has served as a Company director since September 2017
  • Currently he is the CEO of Ironshore Pharmaceuticals, Inc.
  • Additionally he serves as a non-executive board member of Silence Therapeutics (NASDAQ: SLN) and BioHealth Innovation, Inc.
  • Previously at Sigma Tau Pharmaceuticals, Inc. from 2011-2015, he served as CEO
  • Additionally Mr. Lemus served as CFO and Executive V.P. of MorphoSys AG from 1998-2011, taking the company public in Germany’s first biotech IPO
  • Prior to his role at MorphoSys AG, he held various management positions including the companies Hoffman La Roche, Electrolux AB, and Lindt & Spruengli AG (Group Treasurer)
  • B.S., M.S., M.B.A., CPA